Characterization of the Endocannabinoid System in Gliomas and its Implication for novel Treatment Concepts
Autor: | Eifer, AH, Knobbe-Thomsen, CB, Reifenberger, G |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: | |
Zdroj: | Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnP42 /20160914/ |
DOI: | 10.3205/16dgnn44 |
Popis: | Question: It has already been shown that cannabinoids have anti-tumorous effects against malignant gliomas. Cannabinoids activate the receptors TRPV1, TRPV2, CB1 and CB2 in the CNS, which are summarized as the receptors of the endogenous cannabinoid system. The endogenous transmitters are endocannabinoids[for full text, please go to the a.m. URL] Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS) |
Databáze: | OpenAIRE |
Externí odkaz: |